The Morita-Baylis-Hillman adducts of β-aryl nitroethylenes with other activated alkenes: Synthesis and anticancer activity studies

Article abstract of DOI:10.1039/b512267h

The Morita-Baylis-Hillman (MBH) adducts of β-aryl nitroethylenes with methyl vinyl ketone (MVK) and acrylate, formed in moderate to good yield when mediated by imidazole/LiCl in THF at room temperature, inhibit HeLa cell proliferation by binding to tubuli

Full text of DOI:10.1039/b512267h

View Online / Journal Homepage / Table of Contents for this issue
COMMUNICATION
www.rsc.org/chemcomm | ChemComm
The Morita–Baylis–Hillman adducts of b-aryl nitroethylenes with other
activated alkenes: synthesis and anticancer activity studies{{
Mamta Dadwal,a Renu Mohan,b Dulal Panda,*b Shaikh M. Mobinc and Irishi N. N. Namboothiri*a
Received (in Cambridge, UK) 30th August 2005, Accepted 18th October 2005
First published as an Advance Article on the web 21st November 2005
DOI: 10.1039/b512267h
dimerization of alkyl vinyl ketone and acrylonitrile,12 and TDAP
The Morita–Baylis–Hillman (MBH) adducts of b-aryl
(tris-dimethylaminophosphine) or DABCO catalyzed dimerization
of acrylate.13 However, to our knowledge, there are only two
reports where activated alkenes have been consciously used as
electrophiles in the MBH reaction.14
nitroethylenes with methyl vinyl ketone (MVK) and acrylate,
formed in moderate to good yield when mediated by imidazole/
LiCl in THF at room temperature, inhibit HeLa cell prolifera-
tion by binding to tubulin.
At first, the reaction of our model substrate 2-nitrovinyl furan
(NVF) 1a with MVK 2 was carried out in the presence of 10 mol%
of various catalysts such as imidazole,15 DMAP,16 DABCO, DBU
and various other catalysts under a variety of conditions (see
supplementary information{).2 However, while imidazole and
DMAP provided isolable amounts of the desired MBH adduct, all
others failed to catalyze the reaction. Subsequently, the amount of
imidazole required to obtain the best yields of the MBH adduct
was confirmed to be 100 mol%.
The coupling of the a-position of activated alkenes with various
carbon electrophiles mediated by a tertiary amine or tertiary
phosphine, popularly known as the Morita–Baylis–Hillman
(MBH) reaction, has emerged as an important C–C bond forming
reaction in organic synthesis.1,2 It provides a simple, convenient
and atom-economical methodology for the synthesis of useful
multifunctional molecules.2 Although various activated alkenes
have been employed in the MBH reaction,2 conjugated nitroalk-
enes3 have not found a place in more than three decades of the
MBH chemistry.4–7 However, the superior Michael acceptor
ability of conjugated nitroalkenes3 together with the well-
recognized status of the nitro group as a synthetic chameleon8
call for greater attention on nitroalkenes as substrates for the
MBH reaction.
Having optimized the amount of imidazole, the co-catalytic
activity of a variety of additives which are capable of (a) forming
imine/iminium of the enone; (b) activating the enone via hydrogen
bonding; and/or (c) inhibiting polymerization of the substrate
(nitroalkene), was investigated (see supplementary information{).
But, any appreciable improvement in the yield could be achieved
only when hydroquinone and p-methoxyphenol were used in
conjunction with imidazole in the reaction between NVF 1a
and MVK 2. However, further attempts to improve the yields
in these imidazole mediated reactions using hydroquinone as the
additive and employing the optimized conditions for the
reaction of other nitroalkenes 1b–e with MVK 2 led to
unsatisfactory results (Table 1). This prompted us to examine
the effect of salt17 on our MBH reaction by employing LiCl as
the additive.18
The ability of nitroalkenes to exhibit important biological
properties and function as key substrates and/or intermediates in
the synthesis of many potent drugs and bioactive natural products
makes them attractive molecules in the biological domain as well.9
Among various biological properties, the anticancer properties of
nitroalkenes have been scarcely investigated.10,11
In this report, we describe our results on the successful MBH
type reaction of b-aryl nitroethylenes with other activated alkenes
such as methyl vinyl ketone (MVK) and acrylate and the
preliminary evaluation of the novel MBH adducts in their ability
to inhibit human cervical cancer (HeLa) cell proliferation by
binding to tubulin.
Table 1 The MBH reaction of b-aryl nitroethylenes 1 with MVK 2 in
the presence of 100 mol% imidazole, and 10 mol% hydroquinone in
THF/H2O (1 : 1) at room temperature
There is a handful of reports in the literature where activated
alkenes underwent self-condensation (dimerization) in the absence
of another electrophile.12,13 These include DABCO catalyzed
aDepartment of Chemistry, Indian Institute of Technology, Bombay,
Mumbai 400 076, India. E-mail: irishi@iitb.ac.in;
Fax: +91-22-2576-7152; Tel: + 91-22-2576-7196
bSchool of Biosciences and Bioengineering, Indian Institute of
Technology, Bombay, Mumbai 400 076, India.
Entry 1, 3 Ar
Time (min) Isolated yield (%) of 3a
E-mail: panda@btc.iitb.ac.in; Fax: +91-22-2572-3480;
Tel: + 91-22-2576-7838
cNational Single Crystal X-ray Diffraction Facility, Indian Institute of
Technology, Bombay, Mumbai 400 076, India
1
2
3
4
5
a
a
b
c
d
e
2-Furyl
2-Thienyl
4-ClPh
4-OMePh
Ph
60
60
120
60
5
39
41
22
16
{ Dedicated to the memory of the late Professor A. K. Lala.
{ Electronic supplementary information (ESI) available: X-ray data for 3g
in CIF format, experimental procedures, full characterization data, copies
of 1H and 13C NMR spectra and HPLC profiles for all the new
compounds. See DOI: 10.1039/b512267h
Polymerization
Complete consumption of 1 was observed in all the cases.
338 | Chem. Commun., 2006, 338–340
This journal is ß The Royal Society of Chemistry 2006

View Online
Although the imidazole mediated reaction of NVF 1a with
MVK 2 in the presence of LiCl in THF/H2O (1 : 1) was complete
in 1 h, it provided only low yield (22%) of the MBH product 3a.
Subsequently, exclusion of water from the reaction mixture led to
isolation of the desired product 3a in satisfactory yield (44%).
Other polar aprotic solvents such as DMF, acetonitrile and
dioxane provided 3a only in much lower yields.
Table 3 The MBH reaction of b-aryl nitroethylenes 1 with ethyl
acrylate 4 in the presence of 100 mol% imidazole, and 0.5 M LiCl in
THF at room temperature
The imidazole–LiCl ratio of 100 mol%/0.5 M was found to be
optimum because increasing the amount of imidazole to 200 mol%
or LiCl to 1, 2 and 3 M did not have any appreciable influence on
the yield. On the other hand, decreasing the amount of imidazole
to 50 mol% led to dramatic decrease in the yield (18%). Finally, the
optimum ratio of the MBH substrate 1a and the electrophile 2 was
found to be 1 : 3. While decreasing the amount of MVK 2 led to
decrease in the yield, increasing the ratio from 1 : 3 to 1 : 4 or 1 : 5
did not affect the yield at all.
Entry
1, 5
Time (h)
Isolated yield (%) of 5a
1
2
3
4
a
a
g
h
i
56
34
88
90
21
18
21
24
5–12% of 1 was recovered.
In view of the fact that stoichiometric amounts of imidazole in
conjunction with 0.5 M LiCl in THF emerged as the best system
for the MBH reaction of NVF 1a with MVK 2, the scope of the
reaction was extended by reacting a variety of aromatic and
heteroaromatic nitroalkenes 1b–j with MVK 2 (Table 2, Entries
2–10). Although the chemical yields were moderate in these cases
(28–60%), clean, isomerically pure products 3a–j were isolated after
column chromatography.
NOEs with the benzylic olefinic proton. In fact, all the reactions
provided isomerically pure MBH adducts and there was no
evidence for the formation of the other geometrical isomer. The
structure was further unambiguously established by single crystal
X-ray analysis of 3g (see also supplementary information{).19
The effect of the MBH adducts on human cervical cancer
(HeLa) cells were examined by incubating HeLa cells with 5 mM
and 25 mM of the MBH adducts 3a–j, 5a and 5g–i for 24 hours.20
While most of the MBH adducts produced 70–100% inhibition of
HeLa cell proliferation at 25 mM concentrations, three of the
MBH adducts, viz. 3e, 3f and 3g were found to produce more than
70% inhibition even at 5 mM concentration.{ MBH adduct 3f was
found to be the most potent inhibitor of HeLa cell proliferation
among the tested compounds producing 80% inhibition at 5 mM.
To determine the binding affinity of MBH adducts 3a–j, 5a and
5g–i to tubulin, tubulin (1 mM) was incubated with 10 mM each of
all the 14 MBH adducts for 30 min at room temperature.21 In all
the cases, a decrease in the intrinsic tryptophan fluorescence of
tubulin was observed which confirmed that all the compounds
were binding to tubulin.{
Having established the experimental conditions for the reaction
between nitroalkenes 1 and MVK 2, we explored the reactivity of
other activated alkenes as electrophiles under these conditions.
Thus, selected nitroalkenes 1a and 1g–i were reacted with ethyl
acrylate 4 which afforded the desired MBH products 5a and 5g–i,
respectively, though, in low yield (Table 3, Entries 1–4). All our
attempts to use other activated alkenes such as acrolein,
acrylonitrile, acrylamide and nitroethylene as terminal electrophiles
have not been successful.
The geometry of the double bond in products 3 and 5 was
confirmed to be E by performing 2D-NOESY experiment on a
representative compound 3g. One of the CH2 groups and the CH3
group in 3g have strong NOEs with the Ar protons, but only weak
In conclusion, activated alkenes such as MVK and acrylate
reacted as electrophiles in the MBH reaction of a variety of
aromatic and heteroaromatic nitroalkenes and provided novel
a-substituted nitroalkenes. Normally, b-substituted activated
alkenes do not react or react only sluggishly in the MBH type
reactions. However, in the case of nitroalkenes, b-substituted ones
were found to react satisfactorily. One of the MBH adducts was
found to be a potent inhibitor of HeLa cell proliferation at 5 mM
concentrations by binding to tubulin. Applications of these MBH
adducts for the synthesis of novel 1,4-dicarbonyl compounds, 1,4-
amino alcohols, c-amino acids etc will be reported in due course.
We thank CSIR and DBT, India, for financial assistance, SAIF,
IIT Bombay, for NMR data, Dr Rachel Persky, Bar-Ilan
University, Israel, for the HRMS data for some of the compounds
and Mr Madhu Ganesh, Department of Chemistry, IIT Bombay,
for the HPLC profiles.
Table 2 The MBH reaction of b-aryl nitroethylenes 1 with MVK 2 in
the presence of 100 mol% imidazole, and 0.5 M LiCl in THF at room
temperature
Entry 1, 3 Ar
Time (h) Isolated yield (%) of 3a
1
2
3
4
5
6
7
8
9
a
b
c
d
e
f
g
h
i
2-Furyl
2-Thienyl
3-Furyl
3-Thienyl
4-ClPh
4-OMePh
Ph
3,4-(OCH2O)Ph 48
3,4-(OMe)2Ph
4-CF3Ph
48
50
48
48
72
80
20
44
40
42
41
39
36
34
47
60
28
Notes and references
56
6
1 (a) K. Morita, Z. Suzuki and H. Hirose, Bull. Chem. Soc. Jpn., 1968, 41,
2815; (b) A. B. Baylis and M. E. D. Hillman, Ger. Offen., 1972, DE
2155113; (A. B. Baylis and M. E. D. Hillman), Chem. Abs., 1972, 77,
10
a
j
15–23% of 1 was recovered.
This journal is ß The Royal Society of Chemistry 2006
Chem. Commun., 2006, 338–340 | 339

View Online
434174; M. E. D. Hillman and A. B. Baylis, U. S. Patent, 1973, US
3743669.
2 For recent reviews: (a) D. Basavaiah, A. J. Rao and T. Satyanarayana,
Chem. Rev., 2003, 103, 811; (b) T. Kataoka and H. Kinoshita, Eur.
J. Org. Chem., 2005, 45.
3 For a recent review: O. M. Berner, L. Tedeschi and D. Enders, Eur.
J. Org. Chem., 2002, 1877.
4 Baylis and Hillman in their original patent (Ref. 1b) have reported the
reaction between nitroethylene and acetaldehyde in the presence of
DABCO. However, no details or further reports on this or similar
reactions are available.
11 For the evaluation of nitroalkenes and their a-hydroxymethylated
derivatives (MBH adducts with formaldehyde) for their anticancer
activity by targeting microtubules/tubulins: R. Mohan, N. Rastogi, I. N.
N. Namboothiri, S. M. Mobin and D. Panda, unpublished results.
12 (a) D. Basavaiah, V. V. L. Gowriswari and T. K. Bharathi, Tetrahedron
Lett., 1987, 28, 4591; (b) D. Basavaiah, V. V. L. Gowriswari,
P. Dharma Rao and T. K. Bharathi, J. Chem. Res. (S), 1995, 267.
13 (a) H. Amri, M. Rambaud and J. Villieras, Tetrahedron Lett., 1989, 30,
7381; (b) S. E. Drewes, N. D. Emslie and N. Karodia, Synth. Commun.,
1990, 20, 1915.
14 (a) T. Kitazume, K. Tamura, Z. Jiang, N. Miake and I. Kawasaki,
J. Fluor. Chem., 2002, 115, 49; (b) J. R. Hwu, G. H. Hakimelahi and
C. -T. Chou, Tetrahedron Lett., 1992, 33, 6469.
15 For a recent imidazole catalyzed MBH reaction: S. Luo, P. G. Wang
and J.- P. Cheng, J. Org. Chem., 2004, 69, 555.
5 For a-hydroxymethylation of nitroalkenes via the MBH reaction, see:
N. Rastogi, I. N. N. Namboothiri and M. Cojocaru, Tetrahedron Lett.,
2004, 45, 4745.
6 For reaction between aliphatic nitroalkenes and ethyl-2-bromomethyl-
acrylate under the DBU catalyzed conditions: R. Ballini, L. Barboni,
G. Bosica, D. Fiorini, E. Mignini, A. Palmieri, Tetrahedron, 2004, 60,
4995. This reaction apparently involves an overall allylic displacement of
bromide and the product is not a conjugated nitroalkene.
7 The reluctance of the nitroalkenes, despite being powerful Michael
acceptors, is attributable to the reversibility of the first step of the MBH
reaction, i.e. Michael type addition of the tertiary amine or the
phosphine catalyst to nitroalkene, poor nucleophilicity of the nitronate
and/or the propensity of the nitroalkene to undergo polymerization.
8 For a recent review on nitro compounds: R. Ballini and M. Petrini,
Tetrahedron, 2004, 60, 1017.
9 For selected articles: (a) G. W. Kabalka and R. S. Varma, Org. Prep.
Proc. Int., 1987, 19, 283 and the references cited therein; (b) K. Blades,
A. H. Butt, G. S. Cockerill, H. J. Easterfield, T. P. Lequeux and
J. M. Percy, J. Chem. Soc., Perkin Trans. 1, 1999, 3609; (c) Y. Hoashi,
T. Yabuta and Y. Takemoto, Tetrahedron Lett., 2004, 45, 9185.
10 For the antitumor activity of nitroalkene against P-388 murine
lymphocytic leukemia: (a) B. K. Cassels, S. Herreros, C. Ibanez,
M. C. Rezende, C. Sebastian and S. Sepulveda, An. Asoc. Quim.
Argent., 1982, 70, 283, Chem. Abs., 1982, 97, 400402; (b) K. -Y. Zee-
Cheng and C. -C. Cheng, J. Med. Chem., 1969, 12, 157.
16 For a recent DMAP catalyzed MBH reaction: R. Octavio, M. A. de
Souza and M. L. A. A. Vasconcellos, Synth. Commun., 2003, 33, 1383.
17 (a) V. K. Aggarwal, D. K. Dean, A. Mereu and R. Williams, J. Org.
Chem., 2002, 67, 510; (b) A. Kumar and S. S. Pawar, Tetrahedron, 2003,
59, 5019.
18 (a) Recent studies have shown that LiCl catalyzes the MBH reaction by
functioning as a salting out agent: see Ref. 17b; (b) The authors thank
one of the referees for pointing out the analogy of the imidazole/LiCl
catalyst system with the triethylamine/LiCl combination in the
Masamune–Roush variant of the Horner–Wadsworth–Emmons
reaction.
19 Selected X-ray crystallographic data for 3g. C12H13NO3, M = 219.23,
triclinic P1, a = 7.2530(10), b = 7.9810(7), c = 10.7050(9), a = 106.198(7),
3
˚
b = 104.883(9), c = 97.193(9), V = 562.02 (10) A , Z = 2, Dcalc
=
1.295 g cm23, m = 0.094 mm21, 2153 reflections measured, R1 = 0.0453,
Rw = 0.1010. CCDC 283074. For crystallographic data in CIF or other
electronic format see DOI: 10.1039/b512267h.
20 For a recent study on the inhibition of HeLa cell proliferation: K. Gupta,
J. Bishop, A. Peck, J. Brown, L. Wilson and D. Panda, Biochemistry,
2004, 43, 6645.
21 For a recent tubulin binding study: K. Gupta and D. Panda,
Biochemistry, 2002, 41, 13029.
340 | Chem. Commun., 2006, 338–340
This journal is ß The Royal Society of Chemistry 2006